CompletedNCT00351156

Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease

Studying Gaucher disease

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Amicus Therapeutics
Principal Investigator: Karin Ludwig, M.D.
Amicus Therapeutics, Inc.
Intervention: Blood sample(procedure)
Enrollment: 50 enrolled
Eligibility: All sexes
Timeline: 2006 – 2007

Study locations (7)

University of California - San Francisco, San Francisco, California, United States
University Research Foundation for Lysosomal Storage Diseases, Inc., Coral Springs, Florida, United States
Emory University Lysosomal Storage Disease Center, Decatur, Georgia, United States
National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, United States
New York University School of Medicine, Neurogenetics Department, New York, New York, United States
Lysosomal Disease Center, Cincinnati Children's Hospital, Cincinnati, Ohio, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00351156 on ClinicalTrials.gov

Other trials for Gaucher disease

Additional recruiting or active studies for the same condition.

See all trials for Gaucher disease →

← Back to all trials